Latest news
TYRA's dabogratinib trial in 2026 could validat... - PluangPluang · Mon, 10 Aug 2026 07:26:35 GMTHC Wainwright Brokers Lower Earnings Estimates for TYRA - MarketBeatMarketBeat · Fri, 07 Aug 2026 13:33:58 GMTTyra Biosciences (TYRA) Projected to Announce Earnings on Thursday - MarketBeatMarketBeat · Thu, 06 Aug 2026 07:40:16 GMTTyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeatMarketBeat · Thu, 06 Aug 2026 06:59:34 GMTBlackRock, Inc. Expands Tyra Biosciences (TYRA) Stake with Strat - GuruFocusGuruFocus · Thu, 06 Aug 2026 03:43:51 GMTJefferies Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $42 - MoomooMoomoo · Wed, 05 Aug 2026 23:31:00 GMTTyra Biosciences (TYRA) Reports Q2 Results, Is The Pipeline Potential Already Priced In? - simplywall.stsimplywall.st · Wed, 05 Aug 2026 20:38:05 GMTTYRA Shares Drop Amid Market Volatility; Price-to-Sales Highligh - GuruFocusGuruFocus · Wed, 05 Aug 2026 19:27:28 GMT